+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Pharmaceutical Excipients Market by Product ((Organic (Oleochemicals, Cellulose, Glycols), Inorganic)), Functionality (Fillers & Diluents, Binders, Lubricants), Formulation (Oral, Parenteral), Functionality Application (Stabilizers) - Global Forecast to 2030

  • PDF Icon

    Report

  • 633 Pages
  • July 2025
  • Region: Global
  • Markets and Markets
  • ID: 5308866
The global pharmaceutical excipients market is projected to reach USD 14.86 billion by 2030 from USD 11.03 billion in 2025, at a CAGR of 6.1% during the forecast period. The expansion of the Pharmaceutical Excipients market has been predominantly driven by the Surging demand for pharmaceutical products and generic medicines, and R&D investments for novel excipient development are predicted to uplift the market in the coming years. Additionally, partnerships and collaboration with pharmaceutical companies and increased emphasis on patient-centric formulations will provide lucrative market growth opportunities. However, regulatory stringency and steep development costs are predicted to restrict the market.

The fillers & diluents functionality held the highest share in the pharmaceutical excipients market.

The pharmaceutical excipients market, segmented by functionality, includes binders, suspending and viscosity agents, fillers and diluents, flavoring agents and sweeteners, colorants, coating agents, lubricants and glidants, preservatives, disintegrants, emulsifying agents, and other specialized roles. Among these, fillers and diluents play a critical role, especially in the production of solid oral dosage forms like tablets and capsules. Their importance continues to grow with the rising demand for oral medications, which remain the most preferred route due to ease of administration and patient compliance.

Fillers and diluents provide bulk to formulations containing small amounts of active pharmaceutical ingredients and help ensure accurate dosage and improved content uniformity. From a manufacturing perspective, they contribute significantly to formulation stability, ease of processing, and scalability in mass production. They simplify processes such as blending, tableting, and encapsulation while enhancing the mechanical strength of tablets. For patients, these excipients improve mouthfeel, taste, and handling, which are crucial factors for pediatric and geriatric populations. As drug formulations become more complex, the demand for high-performance, multifunctional fillers and diluents that support controlled release and bioavailability enhancement is also rising, presenting significant growth opportunities in this excipient category.

The oral formulations segment reported the highest share of the formulations segment in 2024.

The pharmaceutical excipients market is categorized based on formulation types into oral formulations, topical formulations, parenteral formulations, and other formulations. Among these, the oral formulations segment held the largest market share in 2024, reflecting its dominance as the most widely used and traditional drug delivery method. The convenience, cost-effectiveness, and high patient compliance associated with oral administration make it a preferred choice for patients and healthcare providers. This segment continues to expand due to the rising demand for tablets, capsules, and other solid oral dosage forms.

Furthermore, the rapid growth of the biopharmaceutical and generics industries is playing a pivotal role in driving demand for high-quality excipients that enhance drug stability, solubility, and bioavailability in oral products. The increasing prevalence of chronic conditions requiring long-term medication and the trend toward self-administration of drugs also contribute to the growth of this segment. As a result, pharmaceutical companies are investing in innovative oral drug formulations, boosting the need for advanced excipients tailored to these needs.

Asia Pacific is expected to grow at the highest CAGR in the global pharmaceutical excipients market from 2025 to 2030.

The pharmaceutical excipients market in the Asia Pacific region is expected to grow robustly and register the highest CAGR among all regions during the forecast period. Several interrelated factors are driving this expansion. One of the key advantages is the region’s cost-effective manufacturing capabilities, which make it an attractive hub for pharmaceutical production and outsourcing. Countries like India, China, and South Korea offer abundant raw material availability, skilled labor, and favorable government policies that support pharmaceutical R&D and export-oriented manufacturing.

Additionally, the Asia Pacific region has relatively lenient regulatory frameworks compared to Western markets, which accelerates product development and time-to-market. The rapid rise in per capita income, growing awareness of health and wellness, and increased healthcare spending are further fueling demand for generic drugs and, by extension, pharmaceutical excipients. Moreover, a surge in lifestyle-related chronic diseases and expanding geriatric populations have led to greater demand for innovative drug formulations, including oral solids and topical applications. These trends create significant opportunities for local and global excipient manufacturers to expand operations, invest in infrastructure, and form strategic partnerships to meet the growing regional demand.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side - 70% and Demand Side - 30%
  • By Designation: Managers - 45%, CXOs and Directors - 30%, and Executives - 25%
  • By Region: North America - 40%, Europe - 25%, the Asia Pacific - 25%, Latin America - 5%, and the Middle East & Africa - 5%

List of Key Companies Profiled in the Report

Key players in the pharmaceutical excipients market include International Flavors & Fragrances Inc. (US), Ashland Inc. (US), Evonik Industries AG (Germany), BASF SE (Germany), Kerry Group plc (Ireland), Roquette Frères (France), MERCK KGaA (Germany), Associated British Foods plc (UK), ADM (US), Wacker Chemie AG (Germany), Air Liquide (France), DOW (US), Berkshire Hathaway Inc. (US), Colorcon (US), DFE PHARMA (Germany), Actylis (US), Croda International Plc(UK), Chemie Trade(India), Gattefossé (France), JRS Pharma(US), and Shin-Etsu Chemical Co., Ltd. (Japan).

Research Coverage

This research report categorizes the pharmaceutical excipients market by Product [(Organic (Oleochemicals, Carbohydrates, Petrochemicals, Proteins, and Other Organic Chemicals), Inorganic (Calcium Phosphate, Metal Oxides, Halites, Calcium Carbonate, Calcium Sulfate, Other Inorganic Chemicals), Other chemicals], by Functionality (Fillers & Diluents, Suspending & Viscosity Agents, Coating Agents, Binders, Flavoring Agents & Sweeteners, Disintegrants, Colorants, Lubricants & Glidants, Preservatives, Emulsifying Agents, and Other Functionalities), by formulation (Oral (Tablets, Capsules, Liquid Formulations and other oral formulations), Topical Formulations, Parenteral Formulations, and Other Formulations), by Functionality Application (Stabilizers, Taste Making, Modified Release, Solubility & Bioavailability Enhancement and Other Functionality Applications), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the pharmaceutical excipients market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New approvals/launches, collaborations, acquisitions, and recent developments associated with the pharmaceutical excipients market.

Reasons to Buy this Report

The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical excipients market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Surging demand for generic medications and pharmaceutical formulations, Increased R&D investments to develop novel excipients, A growing focus on patient-centric drug formulations, Strategic collaborations and partnerships with pharmaceutical firms), restraints (Strict and complex regulatory frameworks, High costs associated with excipient development and manufacturing), opportunities (Increasing interest in functional and multifunctional excipients, Technological advancements, particularly in nanotechnology, Expansion into emerging economies across Asia Pacific and Latin America), and Challenges (Ongoing concerns about excipient safety and quality standards, Limited availability and fluctuating costs of key raw materials).
  • Product Development/Innovation: Detailed insights on upcoming products, research and development activities, and new product approvals/launches in the Pharmaceutical Excipients market.
  • Market Development: Comprehensive information about lucrative markets; the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical excipients market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/ approvals, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the pharmaceutical excipients market.

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Segmentation
1.3.2 Regional Scope
1.3.3 Inclusions and Exclusions
1.3.4 Years Considered
1.4 Currency Considered
1.5 Stakeholders
1.6 Summary of Changes
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Objectives of Secondary Research
2.1.1.2 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primary Interviews
2.1.2.2 Key Objectives of Primary Research
2.2 Market Estimation
2.2.1 Global Market Estimation
2.2.1.1 Company Revenue Analysis (Bottom-Up Approach)
2.2.1.2 Revenue Share Analysis
2.2.1.3 Repository Analysis
2.2.1.4 Primary Interviews
2.2.2 Insights from Primary Experts
2.2.3 Segmental Market Size Estimation (Top-Down Approach)
2.3 Growth Rate Projections
2.4 Data Triangulation
2.5 Research Assumptions
2.6 Research Limitations
2.7 Risk Analysis
3 Executive Summary
4 Premium Insights
4.1 Pharmaceutical Excipients Market Overview
4.2 North America Pharmaceutical Excipients Market
4.3 Pharmaceutical Excipients Market: Geographic Growth Opportunities
4.4 Pharmaceutical Excipients Market: Emerging Vs. Developed Markets, 2025 Vs. 2030 (USD Million)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Surging Demand for Generic Medications and Pharmaceutical Formulations.
5.2.1.2 Increased R&D Investments to Develop Novel Excipients
5.2.1.3 Growing Focus on Patient-Centric Drug Formulations
5.2.1.4 Strategic Collaborations and Partnerships Among Pharmaceutical Firms
5.2.2 Restraints
5.2.2.1 Strict and Complex Regulatory Frameworks
5.2.2.2 High Cost of Excipient Development and Manufacturing
5.2.3 Opportunities
5.2.3.1 Increasing Interest in Functional and Multifunctional Excipients
5.2.3.2 Technological Advancements in Nanotechnology
5.2.3.3 Market Opportunities in Emerging Economies
5.2.4 Challenges
5.2.4.1 Ongoing Concerns About Excipient Safety and Quality Standards
5.2.4.2 Limited Availability and Fluctuating Costs of Key Raw Materials
5.3 Trends/Disruptions Impacting Customer Business
5.4 Pricing Analysis
5.4.1 Indicative Pricing Analysis, by Key Player
5.4.2 Indicative Pricing Analysis, by Region
5.5 Value Chain Analysis
5.6 Supply Chain Analysis
5.7 Ecosystem Analysis
5.8 Investment and Funding Scenario
5.9 Technology Analysis
5.9.1 Key Technologies
5.9.1.1 Co-Processed Excipient Technology
5.9.1.2 Nanotechnology-Based Excipients
5.9.2 Complementary Technologies
5.9.2.1 3D Printing/Additive Manufacturing
5.9.2.2 Process Analytical Technology (Pat)
5.9.3 Adjacent Technologies
5.9.3.1 Artificial Intelligence in Formulation Design
5.9.3.2 Green Chemistry/Sustainability Tech
5.10 Patent Analysis
5.11 Trade Analysis
5.11.1 Trade Data for Hs Code 290545
5.11.1.1 Import Data for Hs Code 290545
5.11.1.2 Export Data for Hs Code 290545
5.11.2 Trade Data for Hs Code 350510
5.11.2.1 Import Data for Hs Code 350510
5.11.2.2 Export Data for Hs Code 350510
5.11.3 Trade Data for Hs Code 290532
5.11.3.1 Import Data for Hs Code 290532
5.11.3.2 Export Data for Hs Code 290532
5.11.4 Trade Data for Hs Code 283650
5.11.4.1 Import Data for Hs Code 283650
5.11.4.2 Export Data for Hs Code 283650
5.11.5 Trade Data for Hs Code 250100
5.11.5.1 Import Data for Hs Code 250100
5.11.5.2 Export Data for Hs Code 250100
5.11.6 Trade Data for Hs Code 290543
5.11.6.1 Import Data for Hs Code 290543
5.11.6.2 Export Data for Hs Code 290543
5.11.7 Trade Data for Hs Code 3912
5.11.7.1 Import Data for Hs Code 3912
5.11.7.2 Export Data for Hs Code 3912
5.12 Key Conferences and Events, 2025-2026
5.13 Regulatory Landscape
5.13.1 Regulatory Framework
5.13.1.1 Us
5.13.1.2 Europe
5.13.1.3 China
5.13.1.4 India
5.13.1.5 Brazil
5.13.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.14 Porter's Five Forces Analysis
5.14.1 Bargaining Power of Suppliers
5.14.2 Bargaining Power of Buyers
5.14.3 Threat of New Entrants
5.14.4 Threat of Substitutes
5.14.5 Intensity of Competitive Rivalry
5.15 Key Stakeholders and Buying Criteria
5.15.1 Key Stakeholders in Buying Process
5.15.2 Key Buying Criteria
5.16 Impact of Ai/Gen Ai on Pharmaceutical Excipients Market
5.16.1 Introduction
5.16.2 Market Potential of Ai on Pharmaceutical Excipients
5.16.3 Ai Use Cases
5.16.4 Key Companies Implementing Ai
5.16.5 Future of Generative Ai in Pharmaceutical Excipient Ecosystem
5.17 Impact of 2025 US Tariff on Pharmaceutical Excipients Market
5.17.1 Introduction
5.17.2 Key Tariff Rates
5.17.3 Price Impact Analysis
5.17.4 Impact on Country/Region
5.17.4.1 North America
5.17.4.1.1 Us
5.17.4.2 Europe
5.17.4.3 Asia-Pacific
5.17.5 Impact on End-Use Industries
6 Pharmaceutical Excipients Market, by Product
6.1 Introduction
6.2 Organic Chemicals
6.2.1 Oleochemicals
6.2.1.1 Fatty Alcohols
6.2.1.1.1 Need for Improved Drug Absorption to Augment Growth
6.2.1.2 Mineral Stearates
6.2.1.2.1 Wide Use of Magnesium Stearates as Excipients in Nutraceutical and Pharmaceutical Formulations to Drive Market
6.2.1.3 Glycerin
6.2.1.3.1 Non-Toxic, Colorless, and Odorless Properties to Encourage Growth
6.2.1.4 Other Oleochemicals
6.2.2 Carbohydrates
6.2.2.1 Sugars
6.2.2.1.1 Actual Sugars
6.2.2.1.1.1 Growing Use of Actual Sugars in Pediatric Formulations to Propel Market
6.2.2.1.1.2 Lactose
6.2.2.1.1.3 Sucrose
6.2.2.1.1.4 Dextrose (D-Glucose)
6.2.2.1.2 Sugar Alcohols
6.2.2.1.2.1 Surging Trend in Consumer Demand for Healthier Alternatives to Conventional Sweeteners to Fuel Market
6.2.2.1.2.2 Sorbitol
6.2.2.1.2.3 Mannitol
6.2.2.1.2.4 Other Sugar Alcohols
6.2.2.1.3 Artificial Sweeteners
6.2.2.1.3.1 Increasing Use of Sugar Substitutes to Favor Growth
6.2.2.2 Cellulose
6.2.2.2.1 Microcrystalline Cellulose
6.2.2.2.1.1 Versatility, Safety, and Cost-Effectiveness to Facilitate Growth
6.2.2.2.2 Cellulose Ethers
6.2.2.2.2.1 Higher Effectiveness Than Other Water-Soluble Polymers to Fuel Market
6.2.2.2.3 Cmc & Croscarmellose Sodium
6.2.2.2.3.1 Growing Trend of Sourcing Cmc from More Viable Alternatives to Boost Market
6.2.2.2.4 Cellulose Esters
6.2.2.2.4.1 Increasing Focus on Targeted and Sustained-Release Drug Delivery Systems to Sustain Growth
6.2.2.3 Starch
6.2.2.3.1 Modified Starch
6.2.2.3.1.1 Cold-Water Swelling and Gel Barrier Formation Capabilities to Fuel Market
6.2.2.3.2 Dried Starch
6.2.2.3.2.1 Strong Binding and Coating Properties to Augment Growth
6.2.2.3.3 Converted Starch
6.2.2.3.3.1 Enhanced Solubility and Stability for Drugs to Foster Growth
6.2.3 Petrochemicals
6.2.3.1 Glycols
6.2.3.1.1 Polyethylene Glycol
6.2.3.1.1.1 Solubility, Lubricity, and Compatibility with Apis to Drive Market
6.2.3.1.2 Propylene Glycol
6.2.3.1.2.1 Rising Use of Propylene Glycol in Oral and Injectable Formulations to Foster Growth
6.2.3.2 Povidones
6.2.3.2.1 Increasing Demand for Fast-Dissolving Tablets to Spur Growth
6.2.3.3 Mineral Hydrocarbons
6.2.3.3.1 Petrolatum
6.2.3.3.1.1 Strong Presence in Topical Pharmaceutical Formulations to Expedite Growth
6.2.3.3.2 Mineral Waxes
6.2.3.3.2.1 Utilization of Mineral Waxes in Solid and Semi-Solid Dosage to Foster Growth
6.2.3.3.3 Mineral Oils
6.2.3.3.3.1 Extensive Use of Mineral Oils as Solvents and Emollients to Propel Market
6.2.3.4 Acrylic Polymers
6.2.3.4.1 Wide Use of Acrylic Polymers in Controlled-Release Drug Formulations to Drive Market
6.2.3.5 Other Petrochemicals
6.2.4 Proteins
6.2.4.1 Growing Applications of Proteins as Carriers for Microparticles and Nanoparticles to Propel Market
6.2.5 Other Organic Chemicals
6.3 Inorganic Chemicals
6.3.1 Calcium Phosphate
6.3.1.1 Chemical Purity and Low Incompatibility with Drugs to Aid Growth
6.3.2 Metal Oxides
6.3.2.1 Availability of Silicon Oxides in the Hydrophobic, Hydrophilic, and Granulated Forms to Aid Market Growth
6.3.3 Halites
6.3.3.1 Increased Utilization of Halites in Vaccines and Controlled-Release Formulations to Foster Growth
6.3.4 Calcium Carbonate
6.3.4.1 Short Disintegration Time and Excellent Mechanical Strength to Expedite Growth
6.3.5 Calcium Sulfate
6.3.5.1 High Quality and Cost Effectiveness to Aid Growth
6.3.6 Other Inorganic Chemicals
6.4 Other Chemicals
7 Pharmaceutical Excipients Market, by Functionality
7.1 Introduction
7.2 Fillers & Diluents
7.2.1 Improved Cohesion and Direct Compression to Amplify Growth
7.3 Suspending & Viscosity Agents
7.3.1 Drug Stability and Taste Masking Advantages to Sustain Growth
7.4 Coating Agents
7.4.1 Increasing Use of Sustained-Release Formulations in Pharma Industry to Drive Market
7.5 Binders
7.5.1 Higher Fluidity and Compressibility to Stimulate Growth
7.6 Flavoring Agents & Sweeteners
7.6.1 Need to Improve Drug Palatability to Advance Growth
7.7 Disintegrants
7.7.1 Need for Rapid Break-Up of Solid Dosage Forms to Foster Growth
7.8 Colorants
7.8.1 Increasing Use of Coloring in Hard and Soft Gelatin Capsules, Tablets, Oral Liquids, and Topical Creams to Boost Market
7.9 Lubricants & Glidants
7.9.1 Non-Toxic Properties to Favor Growth
7.10 Preservatives
7.10.1 Growing Use of Preservatives in Pharmaceutical and Nutraceutical Industry to Drive Market
7.11 Emulsifying Agents
7.11.1 Rising Use of Solubility Enhancement Excipients in Liquid Drug Formulations to Promote Growth
7.12 Other Functionalities
8 Pharmaceutical Excipients Market, by Formulation
8.1 Introduction
8.2 Oral Formulations
8.2.1 Tablets
8.2.1.1 High Palatability and Portability to Support Growth
8.2.2 Capsules
8.2.2.1 Hard-Gelatin Capsules
8.2.2.1.1 Ease of Manufacturing and Versatility to Boost Market
8.2.2.2 Soft-Gelatin Capsules
8.2.2.2.1 Quick-Release Properties to Contribute to Growth
8.2.3 Liquid Formulations
8.2.3.1 Rapid Absorption from Stomach and Intestines to Foster Growth
8.2.4 Other Oral Formulations
8.3 Topical Formulations
8.3.1 Growing Demand for Transdermal Patches and Self-Adhering Transdermal Drug Delivery Systems to Fuel Market
8.4 Parenteral Formulations
8.4.1 Emergence of Biological Molecules to Expedite Growth
8.5 Other Formulations
9 Pharmaceutical Excipients Market, by Functionality Application
9.1 Introduction
9.2 Stabilizers
9.2.1 Improved Drug Shelf Life and Lesser Manufacturing Defects to Promote Growth
9.3 Taste Masking
9.3.1 Growing Preference for Better-Tasting Solid Dosage Forms to Propel Market
9.4 Modified-Release
9.4.1 Increasing Use of Modified-Release Formulations in Pharma Industry to Foster Growth
9.5 Solubility & Bioavailability Enhancement
9.5.1 Increasing Preference for Soluble Compounds to Accelerate Growth
9.6 Other Applications
10 Pharmaceutical Excipients Market, by Region
10.1 Introduction
10.2 Europe
10.2.1 Macroeconomic Analysis for Europe
10.2.2 Germany
10.2.2.1 Booming Pharmaceutical Manufacturing Sector to Aid Growth
10.2.3 Uk
10.2.3.1 Growing Adoption of Generics and Development of Novel Excipients to Fuel Market
10.2.4 France
10.2.4.1 Large Geriatric Population to Support Growth
10.2.5 Italy
10.2.5.1 Budgetary Constraints and Restricted Healthcare Spending to Impede Growth
10.2.6 Spain
10.2.6.1 High Consumption of Biologics to Foster Growth
10.2.7 Rest of Europe
10.3 North America
10.3.1 Macroeconomic Analysis for North America
10.3.2 Us
10.3.2.1 Well-Developed Healthcare Infrastructure and Research Bases to Aid Growth
10.3.3 Canada
10.3.3.1 Rising Prevalence of Cancer to Contribute to Growth
10.4 Asia-Pacific
10.4.1 Macroeconomic Analysis for Asia-Pacific
10.4.2 China
10.4.2.1 Emphasis on Generics and Off-Patent Drugs to Drive Market
10.4.3 Japan
10.4.3.1 Rapid Growth of Elderly Population to Augment Growth
10.4.4 India
10.4.4.1 High Domestic Demand for Pharmaceuticals and Export Volume to Boost Market
10.4.5 South Korea
10.4.5.1 Presence of Leading Contract Research and Development Organizations to Propel Market
10.4.6 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Growing Geriatric Population and Rising Disease Prevalence are Driving Market Growth
10.5.2 Macroeconomic Analysis for Latin America
10.5.3 Brazil
10.5.3.1 Emerging Opportunities for Excipient Manufacturers to Drive Market
10.5.4 Mexico
10.5.4.1 Growing Demand for Affordable Therapies to Boost Market
10.5.5 Rest of Latin America
10.6 Middle East
10.6.1 Growing Focus on Unsaturated Markets to Drive Market
10.6.2 Macroeconomic Analysis for Middle East
10.6.3 Gcc Countries
10.6.3.1 Expanding Healthcare Infrastructure Expansion and Localization of Drug Manufacturing to Bolster Growth
10.6.4 Rest of Middle East
10.7 Africa
10.7.1 Increasing Presence of Major Pharmaceutical Companies to Augment Growth
10.7.2 Macroeconomic Analysis for Africa
11 Competitive Landscape
11.1 Introduction
11.2 Key Player Strategies/Right to Win
11.2.1 Overview of Strategies Adopted by Key Players in Pharmaceutical Excipients Market, 2022-2024
11.3 Revenue Analysis, 2020-2024
11.4 Market Share Analysis, 2024
11.5 Company Valuation and Financial Metrics
11.6 Brand/Product Comparison
11.7 Company Evaluation Matrix: Key Players, 2024
11.7.1 Stars
11.7.2 Emerging Leaders
11.7.3 Pervasive Players
11.7.4 Participants
11.7.5 Competitive Benchmarking: Key Players, 2024
11.7.5.1 Company Footprint
11.7.5.2 Region Footprint
11.7.5.3 Product Footprint
11.7.5.4 Functionality Footprint
11.7.5.5 Functionality Application Footprint
11.8 Company Evaluation Matrix: Startups/Smes, 2024
11.8.1 Progressive Companies
11.8.2 Responsive Companies
11.8.3 Dynamic Companies
11.8.4 Starting Blocks
11.8.5 Competitive Benchmarking: Startups/Smes, 2024
11.8.5.1 Detailed List of Key Startups/Smes
11.8.5.2 Competitive Benchmarking of Key Startups/Smes
11.9 Competitive Scenario
11.9.1 Product Launches and Approvals
11.9.2 Deals
11.9.3 Expansions
12 Company Profiles
12.1 Key Players
12.1.1 International Flavors & Fragrances Inc.
12.1.1.1 Business Overview
12.1.1.2 Products Offered
12.1.1.3 Recent Developments
12.1.1.3.1 Deals
12.1.1.3.2 Expansions
12.1.1.4 Analyst's View
12.1.1.4.1 Key Strengths
12.1.1.4.2 Strategic Choices
12.1.1.4.3 Weaknesses and Competitive Threats
12.1.2 Adm
12.1.2.1 Business Overview
12.1.2.2 Products Offered
12.1.2.3 Recent Developments
12.1.2.3.1 Deals
12.1.2.4 Analyst's View
12.1.2.4.1 Key Strengths
12.1.2.4.2 Strategic Choices
12.1.2.4.3 Weaknesses and Competitive Threats
12.1.3 Roquette Frères
12.1.3.1 Business Overview
12.1.3.2 Products Offered
12.1.3.3 Recent Developments
12.1.3.3.1 Product Launches and Approvals
12.1.3.4 Analyst's View
12.1.3.4.1 Key Strengths
12.1.3.4.2 Strategic Choices
12.1.3.4.3 Weaknesses and Competitive Threats
12.1.4 Basf Se
12.1.4.1 Business Overview
12.1.4.2 Products Offered
12.1.4.3 Recent Developments
12.1.4.3.1 Deals
12.1.4.3.2 Expansions
12.1.4.4 Analyst's View
12.1.4.4.1 Key Strengths
12.1.4.4.2 Strategic Choices
12.1.4.4.3 Weaknesses and Competitive Threats
12.1.5 Evonik
12.1.5.1 Business Overview
12.1.5.2 Products Offered
12.1.5.3 Recent Developments
12.1.5.3.1 Expansions
12.1.5.4 Analyst's View
12.1.5.4.1 Key Strengths
12.1.5.4.2 Strategic Choices
12.1.5.4.3 Weaknesses and Competitive Threats
12.1.6 Ashland
12.1.6.1 Business Overview
12.1.6.2 Products Offered
12.1.6.3 Recent Developments
12.1.6.3.1 Product Launches and Approvals
12.1.7 Kerry Group plc
12.1.7.1 Business Overview
12.1.7.2 Products Offered
12.1.7.3 Recent Developments
12.1.7.3.1 Deals
12.1.8 Merck
12.1.8.1 Business Overview
12.1.8.2 Products Offered
12.1.8.3 Recent Developments
12.1.8.3.1 Deals
12.1.9 Associated British Foods plc
12.1.9.1 Business Overview
12.1.9.2 Products Offered
12.1.9.3 Recent Developments
12.1.9.3.1 Deals
12.1.10 Wacker Chemie Ag
12.1.10.1 Business Overview
12.1.10.2 Products Offered
12.1.11 Air Liquide
12.1.11.1 Business Overview
12.1.11.2 Products Offered
12.1.11.3 Recent Developments
12.1.11.3.1 Product Launches and Approvals
12.1.12 Dow
12.1.12.1 Business Overview
12.1.12.2 Products Offered
12.1.13 Berkshire Hathaway (Lubrizol Corporation)
12.1.13.1 Business Overview
12.1.13.2 Products Offered
12.1.13.3 Recent Developments
12.1.13.3.1 Product Launches and Approvals
12.1.14 Colorcon, Inc.
12.1.14.1 Business Overview
12.1.14.2 Products Offered
12.1.14.3 Recent Developments
12.1.14.3.1 Product Launches and Approvals
12.1.14.3.2 Deals
12.1.14.3.3 Expansions
12.1.15 Dfe Pharma
12.1.15.1 Business Overview
12.1.15.2 Products Offered
12.1.15.3 Recent Developments
12.1.15.3.1 Deals
12.1.16 Actylis
12.1.16.1 Business Overview
12.1.16.2 Products Offered
12.1.16.3 Recent Developments
12.1.16.3.1 Deals
12.1.17 Croda International plc
12.1.17.1 Business Overview
12.1.17.2 Products Offered
12.1.17.3 Recent Developments
12.1.17.3.1 Deals
12.1.17.3.2 Expansions
12.1.18 Chemie Trade
12.1.18.1 Business Overview
12.1.18.2 Products Offered
12.1.19 Gattefossé
12.1.19.1 Business Overview
12.1.19.2 Products Offered
12.1.20 J. Rettenmaier & Söhne GmbH + Co Kg
12.1.20.1 Business Overview
12.1.20.2 Products Offered
12.1.21 Shin-Etsu Chemical Co., Ltd.
12.1.21.1 Business Overview
12.1.21.2 Products Offered
12.1.21.3 Recent Developments
12.1.21.3.1 Deals
12.1.21.3.2 Expansions
12.2 Other Players
12.2.1 Innophos
12.2.2 Meggle GmbH & Co. Kg
12.2.3 Fuji Chemical Industries Co., Ltd.
12.2.4 Corel Pharma Chem
12.2.5 Biogrund
12.2.6 Nitika Pharmaceutical Specialties Pvt. Ltd.
12.2.7 R.T. Vanderbilt Holding Company, Inc.
12.2.8 Beneo
12.2.9 Siagachi Industries
12.2.10 Jh Nanhang Life Sciences Co., Ltd.
13 Appendix
13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options
List of Tables
Table 1 Pharmaceutical Excipients Market: Inclusions and Exclusions
Table 2 Impact Analysis of Supply-Side and Demand-Side Factors
Table 3 Pharmaceutical Excipients Market: Risk Analysis
Table 4 Pharmaceutical Excipients Market: Impact Analysis of Market Dynamics
Table 5 Impending and Ongoing Patent Expiry of Blockbuster Therapeutics, 2023-2035
Table 6 List of Multifunctional Excipients
Table 7 Indicative Pricing Analysis of Excipient Products, by Key Player, 2024
Table 8 Indicative Pricing Analysis of Excipient Products, by Region, 2024
Table 9 Pharmaceutical Excipients Market: Role of Companies in Ecosystem
Table 10 Pharmaceutical Excipients Market: Number of Patents Filed, 2014-2024
Table 11 Innovations and Patent Registrations, 2022-2023
Table 12 Import Data for Hs Code 290545 (Glycerol), 2020-2024 (USD)
Table 13 Import Data for Hs Code 290545 (Glycerol), 2020-2024 (Tons)
Table 14 Export Data for Hs Code 290545 (Glycerol), 2020-2024 (USD)
Table 15 Export Data for Hs Code 290545 (Glycerol), 2020-2024 (Tons)
Table 16 Import Data for Hs Code 350510 (Dextrins and Other Modified Starches, E.G. Pregelatinised or Esterified Starches), 2020-2024 (USD)
Table 17 Import Data for Hs Code 350510 (Dextrins and Other Modified Starches, E.G. Pregelatinised or Esterified Starches), 2020-2024 (Tons)
Table 18 Export Data for Hs Code 350510 (Dextrins and Other Modified Starches, E.G. Pregelatinised or Esterified Starches), 2020-2024 (USD)
Table 19 Export Data for Hs Code 350510 (Dextrins and Other Modified Starches, E.G. Pregelatinised or Esterified Starches), 2020-2024 (Tons)
Table 20 Import Data for Hs Code 290532 (Propylene Glycol "Propane-1,2-Diol), 2020-2024 (USD)
Table 21 Import Data for Hs Code 290532 (Propylene Glycol "Propane-1,2-Diol), 2020-2024 (Tons)
Table 22 Export Data for Hs Code 290532 (Propylene Glycol "Propane-1,2-Diol), 2020-2024 (USD)
Table 23 Export Data for Hs Code 290532 (Propylene Glycol "Propane-1,2-Diol), 2020-2024 (Tons)
Table 24 Import Data for Hs Code 283650 (Calcium Carbonate), 2020-2024 (USD)
Table 25 Import Data for Hs Code 283650 (Calcium Carbonate), 2020-2024 (Tons)
Table 26 Export Data for Hs Code 283650 (Calcium Carbonate), 2020-2024 (USD)
Table 27 Export Data for Hs Code 283650 (Calcium Carbonate), 2020-2024 (Tons)
Table 28 Import Data for Hs Code 250100 (Salts, Incl. Table Salt and Denatured Salt, and Pure Sodium Chloride), 2020-2024 (USD)
Table 29 Import Data for Hs Code 250100 (Salts, Incl. Table Salt and Denatured Salt, and Pure Sodium Chloride), 2020-2024 (Tons)
Table 30 Export Data for Hs Code 250100 (Salts, Incl. Table Salt and Denatured Salt, and Pure Sodium Chloride), 2020-2024 (USD)
Table 31 Export Data for Hs Code 250100 (Salts, Incl. Table Salt and Denatured Salt, and Pure Sodium Chloride), 2020-2024 (Tons)
Table 32 Import Data for Hs Code 290543 (Mannitol), 2020-2024 (USD)
Table 33 Import Data for Hs Code 290543 (Mannitol), 2020-2024 (Tons)
Table 34 Export Data for Hs Code 290543 (Mannitol), 2020-2024 (USD)
Table 35 Export Data for Hs Code 290543 (Mannitol), 2020-2024 (Tons)
Table 36 Import Data for Hs Code: 3912 (Cellulose and Its Chemical Derivatives, N.E.S., in Primary Forms), 2020-2024 (USD)
Table 37 Import Data for Hs Code: 3912 (Cellulose and Its Chemical Derivatives, N.E.S., in Primary Forms), 2020-2024 (Tons)
Table 38 Export Data for Hs Code: 3912 (Cellulose and Its Chemical Derivatives, N.E.S., in Primary Forms), 2020-2024 (USD)
Table 39 Export Data for Hs Code: 3912 (Cellulose and Its Chemical Derivatives, N.E.S., in Primary Forms), 2020-2024 (Tons)
Table 40 Pharmaceutical Excipients Market: Key Conferences and Events, 2025-2026
Table 41 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 42 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 43 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 44 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 45 Middle East & Africa: Regulatory Bodies, Government Agencies, and Other Organizations
Table 46 Pharmaceutical Excipients Market: Porter's Five Forces Analysis
Table 47 Influence of Key Stakeholders on Buying Process, by Product (%)
Table 48 Key Buying Criteria, by End-user
Table 49 Us Adjusted Reciprocal Tariff Rates
Table 50 Comparative Pricing on Key Excipient Pre and Post US 2025 Tariff
Table 51 Impact Analysis on End-Use Industries
Table 52 Pharmaceutical Excipients Market, by Product, 2023-2030 (USD Million)
Table 53 Pharmaceutical Excipients Market for Organic Chemicals, by Type, 2023-2030 (USD Million)
Table 54 Pharmaceutical Excipients Market for Organic Chemicals, by Region, 2023-2030 (USD Million)
Table 55 North America: Pharmaceutical Excipients Market for Organic Chemicals, by Country, 2023-2030 (USD Million)
Table 56 Europe: Pharmaceutical Excipients Market for Organic Chemicals, by Country, 2023-2030 (USD Million)
Table 57 Asia-Pacific: Pharmaceutical Excipients Market for Organic Chemicals, by Country, 2023-2030 (USD Million)
Table 58 Latin America: Pharmaceutical Excipients Market for Organic Chemicals, by Country, 2023-2030 (USD Million)
Table 59 Middle East: Pharmaceutical Excipients Market for Organic Chemicals, by Region, 2023-2030 (USD Million)
Table 60 Pharmaceutical Excipients Market for Oleochemicals, by Type, 2023-2030 (USD Million)
Table 61 Pharmaceutical Excipients Market for Oleochemicals, by Region, 2023-2030 (USD Million)
Table 62 North America: Pharmaceutical Excipients Market for Oleochemicals, by Country, 2023-2030 (USD Million)
Table 63 Europe: Pharmaceutical Excipients Market for Oleochemicals, by Country, 2023-2030 (USD Million)
Table 64 Asia-Pacific: Pharmaceutical Excipients Market for Oleochemicals, by Country, 2023-2030 (USD Million)
Table 65 Latin America: Pharmaceutical Excipients Market for Oleochemicals, by Country, 2023-2030 (USD Million)
Table 66 Middle East: Pharmaceutical Excipients Market for Oleochemicals, by Region, 2023-2030 (USD Million)
Table 67 Pharmaceutical Excipients Market for Fatty Alcohols, by Region, 2023-2030 (USD Million)
Table 68 North America: Pharmaceutical Excipients Market for Fatty Alcohols, by Country, 2023-2030 (USD Million)
Table 69 Europe: Pharmaceutical Excipients Market for Fatty Alcohols, by Country, 2023-2030 (USD Million)
Table 70 Asia-Pacific: Pharmaceutical Excipients Market for Fatty Alcohols, by Country, 2023-2030 (USD Million)
Table 71 Latin America: Pharmaceutical Excipients Market for Fatty Alcohols, by Country, 2023-2030 (USD Million)
Table 72 Middle East: Pharmaceutical Excipients Market for Fatty Alcohols, by Region, 2023-2030 (USD Million)
Table 73 Pharmaceutical Excipients Market for Mineral Stearates, by Region, 2023-2030 (USD Million)
Table 74 North America: Pharmaceutical Excipients Market for Mineral Stearates, by Country, 2023-2030 (USD Million)
Table 75 Europe: Pharmaceutical Excipients Market for Mineral Stearates, by Country, 2023-2030 (USD Million)
Table 76 Asia-Pacific: Pharmaceutical Excipients Market for Mineral Stearates, by Country, 2023-2030 (USD Million)
Table 77 Latin America: Pharmaceutical Excipients Market for Mineral Stearates, by Country, 2023-2030 (USD Million)
Table 78 Middle East: Pharmaceutical Excipients Market for Mineral Stearates, by Region, 2023-2030 (USD Million)
Table 79 Pharmaceutical Excipients Market for Glycerin, by Region, 2023-2030 (USD Million)
Table 80 North America: Pharmaceutical Excipients Market for Glycerin, by Country, 2023-2030 (USD Million)
Table 81 Europe: Pharmaceutical Excipients Market for Glycerin, by Country, 2023-2030 (USD Million)
Table 82 Asia-Pacific: Pharmaceutical Excipients Market for Glycerin, by Country, 2023-2030 (USD Million)
Table 83 Latin America: Pharmaceutical Excipients Market for Glycerin, by Country, 2023-2030 (USD Million)
Table 84 Middle East: Pharmaceutical Excipients Market for Glycerin, by Region, 2023-2030 (USD Million)
Table 85 Pharmaceutical Excipients Market for Other Oleochemicals, by Region, 2023-2030 (USD Million)
Table 86 North America: Pharmaceutical Excipients Market for Other Oleochemicals, by Country, 2023-2030 (USD Million)
Table 87 Europe: Pharmaceutical Excipients Market for Other Oleochemicals, by Country, 2023-2030 (USD Million)
Table 88 Asia-Pacific: Pharmaceutical Excipients Market for Other Oleochemicals, by Country, 2023-2030 (USD Million)
Table 89 Latin America: Pharmaceutical Excipients Market for Other Oleochemicals, by Country, 2023-2030 (USD Million)
Table 90 Middle East: Pharmaceutical Excipients Market for Other Oleochemicals, by Region, 2023-2030 (USD Million)
Table 91 Pharmaceutical Excipients Market for Carbohydrates, by Type, 2023-2030 (USD Million)
Table 92 Pharmaceutical Excipients Market for Carbohydrates, by Region, 2023-2030 (USD Million)
Table 93 North America: Pharmaceutical Excipients Market for Carbohydrates, by Country, 2023-2030 (USD Million)
Table 94 Europe: Pharmaceutical Excipients Market for Carbohydrates, by Country, 2023-2030 (USD Million)
Table 95 Asia-Pacific: Pharmaceutical Excipients Market for Carbohydrates, by Country, 2023-2030 (USD Million)
Table 96 Latin America: Pharmaceutical Excipients Market for Carbohydrates, by Country, 2023-2030 (USD Million)
Table 97 Middle East: Pharmaceutical Excipients Market for Carbohydrates, by Region, 2023-2030 (USD Million)
Table 98 Pharmaceutical Excipients Market for Sugars, by Type, 2023-2030 (USD Million)
Table 99 Pharmaceutical Excipients Market for Sugars, by Region, 2023-2030 (USD Million)
Table 100 North America: Pharmaceutical Excipients Market for Sugars, by Country, 2023-2030 (USD Million)
Table 101 Europe: Pharmaceutical Excipients Market for Sugars, by Country, 2023-2030 (USD Million)
Table 102 Asia-Pacific: Pharmaceutical Excipients Market for Sugars, by Country, 2023-2030 (USD Million)
Table 103 Latin America: Pharmaceutical Excipients Market for Sugars, by Country, 2023-2030 (USD Million)
Table 104 Middle East: Pharmaceutical Excipients Market for Sugars, by Region, 2023-2030 (USD Million)
Table 105 Pharmaceutical Excipients Market for Actual Sugars, by Type, 2023-2030 (USD Million)
Table 106 Pharmaceutical Excipients Market for Actual Sugars, by Region, 2023-2030 (USD Million)
Table 107 North America: Pharmaceutical Excipients Market for Actual Sugars, by Country, 2023-2030 (USD Million)
Table 108 Europe: Pharmaceutical Excipients Market for Actual Sugars, by Country, 2023-2030 (USD Million)
Table 109 Asia-Pacific: Pharmaceutical Excipients Market for Actual Sugars, by Country, 2023-2030 (USD Million)
Table 110 Latin America: Pharmaceutical Excipients Market for Actual Sugars, by Country, 2023-2030 (USD Million)
Table 111 Middle East: Pharmaceutical Excipients Market for Actual Sugars, by Region, 2023-2030 (USD Million)
Table 112 Pharmaceutical Excipients Market for Lactose, by Region, 2023-2030 (USD Million)
Table 113 North America: Pharmaceutical Excipients Market for Lactose, by Country, 2023-2030 (USD Million)
Table 114 Europe: Pharmaceutical Excipients Market for Lactose, by Country, 2023-2030 (USD Million)
Table 115 Asia-Pacific: Pharmaceutical Excipients Market for Lactose, by Country, 2023-2030 (USD Million)
Table 116 Latin America: Pharmaceutical Excipients Market for Lactose, by Country, 2023-2030 (USD Million)
Table 117 Middle East: Pharmaceutical Excipients Market for Lactose, by Region, 2023-2030 (USD Million)
Table 118 Pharmaceutical Excipients Market for Sucrose, by Region, 2023-2030 (USD Million)
Table 119 North America: Pharmaceutical Excipients Market for Sucrose, by Country, 2023-2030 (USD Million)
Table 120 Europe: Pharmaceutical Excipients Market for Sucrose, by Country, 2023-2030 (USD Million)
Table 121 Asia-Pacific: Pharmaceutical Excipients Market for Sucrose, by Country, 2023-2030 (USD Million)
Table 122 Latin America: Pharmaceutical Excipients Market for Sucrose, by Country, 2023-2030 (USD Million)
Table 123 Middle East: Pharmaceutical Excipients Market for Sucrose, by Region, 2023-2030 (USD Million)
Table 124 Pharmaceutical Excipients Market for Dextrose (D-Glucose), by Region, 2023-2030 (USD Million)
Table 125 North America: Pharmaceutical Excipients Market for Dextrose (D-Glucose), by Country, 2023-2030 (USD Million)
Table 126 Europe: Pharmaceutical Excipients Market for Dextrose (D-Glucose), by Country, 2023-2030 (USD Million)
Table 127 Asia-Pacific: Pharmaceutical Excipients Market for Dextrose (D-Glucose), by Country, 2023-2030 (USD Million)
Table 128 Latin America: Pharmaceutical Excipients Market for Dextrose (D-Glucose), by Country, 2023-2030 (USD Million)
Table 129 Middle East: Pharmaceutical Excipients Market for Dextrose (D-Glucose), by Region, 2023-2030 (USD Million)
Table 130 Pharmaceutical Excipients Market for Sugar Alcohols, by Type, 2023-2030 (USD Million)
Table 131 Pharmaceutical Excipients Market for Sugar Alcohols, by Region, 2023-2030 (USD Million)
Table 132 North America: Pharmaceutical Excipients Market for Sugar Alcohols, by Country, 2023-2030 (USD Million)
Table 133 Europe: Pharmaceutical Excipients Market for Sugar Alcohols, by Country, 2023-2030 (USD Million)
Table 134 Asia-Pacific: Pharmaceutical Excipients Market for Sugar Alcohols, by Country, 2023-2030 (USD Million)
Table 135 Latin America: Pharmaceutical Excipients Market for Sugar Alcohols, by Country, 2023-2030 (USD Million)
Table 136 Middle East: Pharmaceutical Excipients Market for Sugar Alcohols, by Region, 2023-2030 (USD Million)
Table 137 Pharmaceutical Excipients Market for Sorbitol, by Region, 2023-2030 (USD Million)
Table 138 North America: Pharmaceutical Excipients Market for Sorbitol, by Country, 2023-2030 (USD Million)
Table 139 Europe: Pharmaceutical Excipients Market for Sorbitol, by Country, 2023-2030 (USD Million)
Table 140 Asia-Pacific: Pharmaceutical Excipients Market for Sorbitol, by Country, 2023-2030 (USD Million)
Table 141 Latin America: Pharmaceutical Excipients Market for Sorbitol, by Country, 2023-2030 (USD Million)
Table 142 Middle East: Pharmaceutical Excipients Market for Sorbitol, by Region, 2023-2030 (USD Million)
Table 143 Pharmaceutical Excipients Market for Mannitol, by Region, 2023-2030 (USD Million)
Table 144 North America: Pharmaceutical Excipients Market for Mannitol, by Country, 2023-2030 (USD Million)
Table 145 Europe: Pharmaceutical Excipients Market for Mannitol, by Country, 2023-2030 (USD Million)
Table 146 Asia-Pacific: Pharmaceutical Excipients Market for Mannitol, by Country, 2023-2030 (USD Million)
Table 147 Latin America: Pharmaceutical Excipients Market for Mannitol, by Country, 2023-2030 (USD Million)
Table 148 Middle East: Pharmaceutical Excipients Market for Mannitol, by Region, 2023-2030 (USD Million)
Table 149 Pharmaceutical Excipients Market for Other Sugar Alcohols, by Region, 2023-2030 (USD Million)
Table 150 North America: Pharmaceutical Excipients Market for Other Sugar Alcohols, by Country, 2023-2030 (USD Million)
Table 151 Europe: Pharmaceutical Excipients Market for Other Sugar Alcohols, by Country, 2023-2030 (USD Million)
Table 152 Asia-Pacific: Pharmaceutical Excipients Market for Other Sugar Alcohols, by Country, 2023-2030 (USD Million)
Table 153 Latin America: Pharmaceutical Excipients Market for Other Sugar Alcohols, by Country, 2023-2030 (USD Million)
Table 154 Middle East: Pharmaceutical Excipients Market for Other Sugar Alcohols, by Region, 2023-2030 (USD Million)
Table 155 Pharmaceutical Excipients Market for Artificial Sweeteners, by Region, 2023-2030 (USD Million)
Table 156 North America: Pharmaceutical Excipients Market for Artificial Sweeteners, by Country, 2023-2030 (USD Million)
Table 157 Europe: Pharmaceutical Excipients Market for Artificial Sweeteners, by Country, 2023-2030 (USD Million)
Table 158 Asia-Pacific: Pharmaceutical Excipients Market for Artificial Sweeteners, by Country, 2023-2030 (USD Million)
Table 159 Latin America: Pharmaceutical Excipients Market for Artificial Sweeteners, by Country, 2023-2030 (USD Million)
Table 160 Middle East: Pharmaceutical Excipients Market for Artificial Sweeteners, by Region, 2023-2030 (USD Million)
Table 161 Pharmaceutical Excipients Market for Cellulose, by Type, 2023-2030 (USD Million)
Table 162 Pharmaceutical Excipients Market for Cellulose, by Region, 2023-2030 (USD Million)
Table 163 North America: Pharmaceutical Excipients Market for Cellulose, by Country, 2023-2030 (USD Million)
Table 164 Europe: Pharmaceutical Excipients Market for Cellulose, by Country, 2023-2030 (USD Million)
Table 165 Asia-Pacific: Pharmaceutical Excipients Market for Cellulose, by Country, 2023-2030 (USD Million)
Table 166 Latin America: Pharmaceutical Excipients Market for Cellulose, by Country, 2023-2030 (USD Million)
Table 167 Middle East: Pharmaceutical Excipients Market for Cellulose, by Region, 2023-2030 (USD Million)
Table 168 Pharmaceutical Excipients Market for Microcrystalline Cellulose, by Region, 2023-2030 (USD Million)
Table 169 North America: Pharmaceutical Excipients Market for Microcrystalline Cellulose, by Country, 2023-2030 (USD Million)
Table 170 Europe: Pharmaceutical Excipients Market for Microcrystalline Cellulose, by Country, 2023-2030 (USD Million)
Table 171 Asia-Pacific: Pharmaceutical Excipients Market for Microcrystalline Cellulose, by Country, 2023-2030 (USD Million)
Table 172 Latin America: Pharmaceutical Excipients Market for Microcrystalline Cellulose, by Country, 2023-2030 (USD Million)
Table 173 Middle East: Pharmaceutical Excipients Market for Microcrystalline Cellulose, by Region, 2023-2030 (USD Million)
Table 174 Pharmaceutical Excipients Market for Cellulose Ethers, by Region, 2023-2030 (USD Million)
Table 175 North America: Pharmaceutical Excipients Market for Cellulose Ethers, by Country, 2023-2030 (USD Million)
Table 176 Europe: Pharmaceutical Excipients Market for Cellulose Ethers, by Country, 2023-2030 (USD Million)
Table 177 Asia-Pacific: Pharmaceutical Excipients Market for Cellulose Ethers, by Country, 2023-2030 (USD Million)
Table 178 Latin America: Pharmaceutical Excipients Market for Cellulose Ethers, by Country, 2023-2030 (USD Million)
Table 179 Middle East: Pharmaceutical Excipients Market for Cellulose Ethers, by Region, 2023-2030 (USD Million)
Table 180 Pharmaceutical Excipients Market for Cmc & Croscarmellose Sodium, by Region, 2023-2030 (USD Million)
Table 181 North America: Pharmaceutical Excipients Market for Cmc & Croscarmellose Sodium, by Country, 2023-2030 (USD Million)
Table 182 Europe: Pharmaceutical Excipients Market for Cmc & Croscarmellose Sodium, by Country, 2023-2030 (USD Million)
Table 183 Asia-Pacific: Pharmaceutical Excipients Market for Cmc & Croscarmellose Sodium, by Country, 2023-2030 (USD Million)
Table 184 Latin America: Pharmaceutical Excipients Market for Cmc & Croscarmellose Sodium, by Country, 2023-2030 (USD Million)
Table 185 Middle East: Pharmaceutical Excipients Market for Cmc & Croscarmellose Sodium, by Region, 2023-2030 (USD Million)
Table 186 Pharmaceutical Excipients Market for Cellulose Esters, by Region, 2023-2030 (USD Million)
Table 187 North America: Pharmaceutical Excipients Market for Cellulose Esters, by Country, 2023-2030 (USD Million)
Table 188 Europe: Pharmaceutical Excipients Market for Cellulose Esters, by Country, 2023-2030 (USD Million)
Table 189 Asia-Pacific: Pharmaceutical Excipients Market for Cellulose Esters, by Country, 2023-2030 (USD Million)
Table 190 Latin America: Pharmaceutical Excipients Market for Cellulose Esters, by Country, 2023-2030 (USD Million)
Table 191 Middle East: Pharmaceutical Excipients Market for Cellulose Esters, by Region, 2023-2030 (USD Million)
Table 192 Pharmaceutical Excipients Market for Starch, by Type, 2023-2030 (USD Million)
Table 193 Pharmaceutical Excipients Market for Starch, by Region, 2023-2030 (USD Million)
Table 194 North America: Pharmaceutical Excipients Market for Starch, by Country, 2023-2030 (USD Million)
Table 195 Europe: Pharmaceutical Excipients Market for Starch, by Country, 2023-2030 (USD Million)
Table 196 Asia-Pacific: Pharmaceutical Excipients Market for Starch, by Country, 2023-2030 (USD Million)
Table 197 Latin America: Pharmaceutical Excipients Market for Starch, by Country, 2023-2030 (USD Million)
Table 198 Middle East: Pharmaceutical Excipients Market for Starch, by Region, 2023-2030 (USD Million)
Table 199 Pharmaceutical Excipients Market for Modified Starch, by Region, 2023-2030 (USD Million)
Table 200 North America: Pharmaceutical Excipients Market for Modified Starch, by Country, 2023-2030 (USD Million)
Table 201 Europe: Pharmaceutical Excipients Market for Modified Starch, by Country, 2023-2030 (USD Million)
Table 202 Asia-Pacific: Pharmaceutical Excipients Market for Modified Starch, by Country, 2023-2030 (USD Million)
Table 203 Latin America: Pharmaceutical Excipients Market for Modified Starch, by Country, 2023-2030 (USD Million)
Table 204 Middle East: Pharmaceutical Excipients Market for Modified Starch, by Region, 2023-2030 (USD Million)
Table 205 Pharmaceutical Excipients Market for Dried Starch, by Region, 2023-2030 (USD Million)
Table 206 North America: Pharmaceutical Excipients Market for Dried Starch, by Country, 2023-2030 (USD Million)
Table 207 Europe: Pharmaceutical Excipients Market for Dried Starch, by Country, 2023-2030 (USD Million)
Table 208 Asia-Pacific: Pharmaceutical Excipients Market for Dried Starch, by Country, 2023-2030 (USD Million)
Table 209 Latin America: Pharmaceutical Excipients Market for Dried Starch, by Country, 2023-2030 (USD Million)
Table 210 Middle East: Pharmaceutical Excipients Market for Dried Starch, by Region, 2023-2030 (USD Million)
Table 211 Pharmaceutical Excipients Market for Converted Starch, by Region, 2023-2030 (USD Million)
Table 212 North America: Pharmaceutical Excipients Market for Converted Starch, by Country, 2023-2030 (USD Million)
Table 213 Europe: Pharmaceutical Excipients Market for Converted Starch, by Country, 2023-2030 (USD Million)
Table 214 Asia-Pacific: Pharmaceutical Excipients Market for Converted Starch, by Country, 2023-2030 (USD Million)
Table 215 Latin America: Pharmaceutical Excipients Market for Converted Starch, by Country, 2023-2030 (USD Million)
Table 216 Middle East: Pharmaceutical Excipients Market for Converted Starch, by Region, 2023-2030 (USD Million)
Table 217 Pharmaceutical Excipients Market for Petrochemicals, by Type, 2023-2030 (USD Million)
Table 218 Pharmaceutical Excipients Market for Petrochemicals, by Region, 2023-2030 (USD Million)
Table 219 North America: Pharmaceutical Excipients Market for Petrochemicals, by Country, 2023-2030 (USD Million)
Table 220 Europe: Pharmaceutical Excipients Market for Petrochemicals, by Country, 2023-2030 (USD Million)
Table 221 Asia-Pacific: Pharmaceutical Excipients Market for Petrochemicals, by Country, 2023-2030 (USD Million)
Table 222 Latin America: Pharmaceutical Excipients Market for Petrochemicals, by Country, 2023-2030 (USD Million)
Table 223 Middle East: Pharmaceutical Excipients Market for Petrochemicals, by Region, 2023-2030 (USD Million)
Table 224 Pharmaceutical Excipients Market for Glycols, by Type, 2023-2030 (USD Million)
Table 225 Pharmaceutical Excipients Market for Glycols, by Region, 2023-2030 (USD Million)
Table 226 North America: Pharmaceutical Excipients Market for Glycols, by Country, 2023-2030 (USD Million)
Table 227 Europe: Pharmaceutical Excipients Market for Glycols, by Country, 2023-2030 (USD Million)
Table 228 Asia-Pacific: Pharmaceutical Excipients Market for Glycols, by Country, 2023-2030 (USD Million)
Table 229 Latin America: Pharmaceutical Excipients Market for Glycols, by Country, 2023-2030 (USD Million)
Table 230 Middle East: Pharmaceutical Excipients Market for Glycols, by Region, 2023-2030 (USD Million)
Table 231 Pharmaceutical Excipients Market for Polyethylene Glycol, by Region, 2023-2030 (USD Million)
Table 232 North America: Pharmaceutical Excipients Market for Polyethylene Glycol, by Country, 2023-2030 (USD Million)
Table 233 Europe: Pharmaceutical Excipients Market for Polyethylene Glycol, by Country, 2023-2030 (USD Million)
Table 234 Asia-Pacific: Pharmaceutical Excipients Market for Polyethylene Glycol, by Country, 2023-2030 (USD Million)
Table 235 Latin America: Pharmaceutical Excipients Market for Polyethylene Glycol, by Country, 2023-2030 (USD Million)
Table 236 Middle East: Pharmaceutical Excipients Market for Polyethylene Glycol, by Region, 2023-2030 (USD Million)
Table 237 Pharmaceutical Excipients Market for Propylene Glycol, by Region, 2023-2030 (USD Million)
Table 238 North America: Pharmaceutical Excipients Market for Propylene Glycol, by Country, 2023-2030 (USD Million)
Table 239 Europe: Pharmaceutical Excipients Market for Propylene Glycol, by Country, 2023-2030 (USD Million)
Table 240 Asia-Pacific: Pharmaceutical Excipients Market for Propylene Glycol, by Country, 2023-2030 (USD Million)
Table 241 Latin America: Pharmaceutical Excipients Market for Propylene Glycol, by Country, 2023-2030 (USD Million)
Table 242 Middle East: Pharmaceutical Excipients Market for Propylene Glycol, by Region, 2023-2030 (USD Million)
Table 243 Pharmaceutical Excipients Market for Povidones, by Region, 2023-2030 (USD Million)
Table 244 North America: Pharmaceutical Excipients Market for Povidones, by Country, 2023-2030 (USD Million)
Table 245 Europe: Pharmaceutical Excipients Market for Povidones, by Country, 2023-2030 (USD Million)
Table 246 Asia-Pacific: Pharmaceutical Excipients Market for Povidones, by Country, 2023-2030 (USD Million)
Table 247 Latin America: Pharmaceutical Excipients Market for Povidones, by Country, 2023-2030 (USD Million)
Table 248 Middle East: Pharmaceutical Excipients Market for Povidones, by Region, 2023-2030 (USD Million)
Table 249 Pharmaceutical Excipients Market for Mineral Hydrocarbons, by Type, 2023-2030 (USD Million)
Table 250 Pharmaceutical Excipients Market for Mineral Hydrocarbons, by Region, 2023-2030 (USD Million)
Table 251 North America: Pharmaceutical Excipients Market for Mineral Hydrocarbons, by Country, 2023-2030 (USD Million)
Table 252 Europe: Pharmaceutical Excipients Market for Mineral Hydrocarbons, by Country, 2023-2030 (USD Million)
Table 253 Asia-Pacific: Pharmaceutical Excipients Market for Mineral Hydrocarbons, by Country, 2023-2030 (USD Million)
Table 254 Latin America: Pharmaceutical Excipients Market for Mineral Hydrocarbons, by Country, 2023-2030 (USD Million)
Table 255 Middle East: Pharmaceutical Excipients Market for Mineral Hydrocarbons, by Region, 2023-2030 (USD Million)
Table 256 Pharmaceutical Excipients Market for Petrolatum, by Region, 2023-2030 (USD Million)
Table 257 North America: Pharmaceutical Excipients Market for Petrolatum, by Country, 2023-2030 (USD Million)
Table 258 Europe: Pharmaceutical Excipients Market for Petrolatum, by Country, 2023-2030 (USD Million)
Table 259 Asia-Pacific: Pharmaceutical Excipients Market for Petrolatum, by Country, 2023-2030 (USD Million)
Table 260 Latin America: Pharmaceutical Excipients Market for Petrolatum, by Country, 2023-2030 (USD Million)
Table 261 Middle East: Pharmaceutical Excipients Market for Petrolatum, by Region, 2023-2030 (USD Million)
Table 262 Pharmaceutical Excipients Market for Mineral Waxes, by Region, 2023-2030 (USD Million)
Table 263 North America: Pharmaceutical Excipients Market for Mineral Waxes, by Country, 2023-2030 (USD Million)
Table 264 Europe: Pharmaceutical Excipients Market for Mineral Waxes, by Country, 2023-2030 (USD Million)
Table 265 Asia-Pacific: Pharmaceutical Excipients Market for Mineral Waxes, by Country, 2023-2030 (USD Million)
Table 266 Latin America: Pharmaceutical Excipients Market for Mineral Waxes, by Country, 2023-2030 (USD Million)
Table 267 Middle East: Pharmaceutical Excipients Market for Mineral Waxes, by Region, 2023-2030 (USD Million)
Table 268 Pharmaceutical Excipients Market for Mineral Oils, by Region, 2023-2030 (USD Million)
Table 269 North America: Pharmaceutical Excipients Market for Mineral Oils, by Country, 2023-2030 (USD Million)
Table 270 Europe: Pharmaceutical Excipients Market for Mineral Oils, by Country, 2023-2030 (USD Million)
Table 271 Asia-Pacific: Pharmaceutical Excipients Market for Mineral Oils, by Country, 2023-2030 (USD Million)
Table 272 Latin America: Pharmaceutical Excipients Market for Mineral Oils, by Country, 2023-2030 (USD Million)
Table 273 Middle East: Pharmaceutical Excipients Market for Mineral Oils, by Region, 2023-2030 (USD Million)
Table 274 Pharmaceutical Excipients Market for Acrylic Polymers, by Region, 2023-2030 (USD Million)
Table 275 North America: Pharmaceutical Excipients Market for Acrylic Polymers, by Country, 2023-2030 (USD Million)
Table 276 Europe: Pharmaceutical Excipients Market for Acrylic Polymers, by Country, 2023-2030 (USD Million)
Table 277 Asia-Pacific: Pharmaceutical Excipients Market for Acrylic Polymers, by Country, 2023-2030 (USD Million)
Table 278 Latin America: Pharmaceutical Excipients Market for Acrylic Polymers, by Country, 2023-2030 (USD Million)
Table 279 Middle East: Pharmaceutical Excipients Market for Acrylic Polymers, by Region, 2023-2030 (USD Million)
Table 280 Pharmaceutical Excipients Market for Other Petrochemicals, by Region, 2023-2030 (USD Million)
Table 281 North America: Pharmaceutical Excipients Market for Other Petrochemicals, by Country, 2023-2030 (USD Million)
Table 282 Europe: Pharmaceutical Excipients Market for Other Petrochemicals, by Country, 2023-2030 (USD Million)
Table 283 Asia-Pacific: Pharmaceutical Excipients Market for Other Petrochemicals, by Country, 2023-2030 (USD Million)
Table 284 Latin America: Pharmaceutical Excipients Market for Other Petrochemicals, by Country, 2023-2030 (USD Million)
Table 285 Middle East: Pharmaceutical Excipients Market for Other Petrochemicals, by Region, 2023-2030 (USD Million)
Table 286 Pharmaceutical Excipients Market for Proteins, by Region, 2023-2030 (USD Million)
Table 287 North America: Pharmaceutical Excipients Market for Proteins, by Country, 2023-2030 (USD Million)
Table 288 Europe: Pharmaceutical Excipients Market for Proteins, by Country, 2023-2030 (USD Million)
Table 289 Asia-Pacific: Pharmaceutical Excipients Market for Proteins, by Country, 2023-2030 (USD Million)
Table 290 Latin America: Pharmaceutical Excipients Market for Proteins, by Country, 2023-2030 (USD Million)
Table 291 Middle East: Pharmaceutical Excipients Market for Proteins, by Region, 2023-2030 (USD Million)
Table 292 Pharmaceutical Excipients Market for Other Organic Chemicals, by Region, 2023-2030 (USD Million)
Table 293 North America: Pharmaceutical Excipients Market for Other Organic Chemicals, by Country, 2023-2030 (USD Million)
Table 294 Europe: Pharmaceutical Excipients Market for Other Organic Chemicals, by Country, 2023-2030 (USD Million)
Table 295 Asia-Pacific: Pharmaceutical Excipients Market for Other Organic Chemicals, by Country, 2023-2030 (USD Million)
Table 296 Latin America: Pharmaceutical Excipients Market for Other Organic Chemicals, by Country, 2023-2030 (USD Million)
Table 297 Middle East: Pharmaceutical Excipients Market for Other Organic Chemicals, by Region, 2023-2030 (USD Million)
Table 298 Pharmaceutical Excipients Market for Inorganic Chemicals, by Type, 2023-2030 (USD Million)
List of Figures
Figure 1 Pharmaceutical Excipients Market Segmentation
Figure 2 Pharmaceutical Excipients Regional Scope
Figure 3 Pharmaceutical Excipients Market: Years Considered
Figure 4 Pharmaceutical Excipients Market: Research Design
Figure 5 Pharmaceutical Excipients Market: Key Data from Secondary Sources
Figure 6 Pharmaceutical Excipients Market: Breakdown of Primary Interviews
Figure 7 Pharmaceutical Excipients Market Estimation (Supply-Side Analysis), 2024
Figure 8 Company Revenue Analysis-Based Estimation: Bottom-Up Approach, 2024
Figure 9 Revenue Share Analysis of Sandoz Group Ag, 2024
Figure 10 Pharmaceutical Excipients Market Size Validation from Primary Sources
Figure 11 Pharmaceutical Excipients Market: Top-Down Approach
Figure 12 Pharmaceutical Excipients Market: CAGR Projections
Figure 13 Pharmaceutical Excipients Market: Data Triangulation
Figure 14 Pharmaceutical Excipients Market, by Product, 2025 Vs. 2030 (USD Million)
Figure 15 Pharmaceutical Excipients Market, by Functionality, 2025 Vs. 2030 (USD Million)
Figure 16 Pharmaceutical Excipients Market, by Formulation, 2025 Vs. 2030 (USD Million)
Figure 17 Pharmaceutical Excipients Market, by Functionality Application, 2025 Vs. 2030 (USD Million)
Figure 18 Geographical Snapshot of Pharmaceutical Excipients Market
Figure 19 Growing Demand for Generics and Pharmaceutical Products to Drive Market
Figure 20 Organic Chemicals Segment and US to Lead North American Market in 2025
Figure 21 Germany to Register Highest Growth During Forecast Period
Figure 22 Emerging Markets to Register Higher Growth During Forecast Period
Figure 23 Pharmaceutical Excipients Market: Drivers, Restraints, Opportunities, and Challenges
Figure 24 Global Pharmaceutical R&D Spend, 2018-2028
Figure 25 Revenue Shift and New Pockets for Pharmaceutical Excipient Providers
Figure 26 Indicative Pricing Analysis Excipient Products, 2024
Figure 27 Indicative Pricing Analysis of Excipient Products, by Region, 2024
Figure 28 Pharmaceutical Excipients Market: Value Chain Analysis
Figure 29 Pharmaceutical Excipients Market: Supply Chain Analysis
Figure 30 Pharmaceutical Excipients Market: Ecosystem Analysis
Figure 31 Pharmaceutical Excipients Market: Investment and Funding Scenario, 2022-2024
Figure 32 Pharmaceutical Excipients Market: Patent Analysis, January 2014-December 2024
Figure 33 Pharmaceutical Excipients Market: Porter's Five Forces Analysis
Figure 34 Influence of Key Stakeholders in Buying Process, by Product
Figure 35 Key Buying Criteria, by End-user
Figure 36 Pharmaceutical Excipients Market: Ai Use Cases
Figure 37 Europe: Pharmaceutical Excipients Market Snapshot
Figure 38 Asia-Pacific: Pharmaceutical Excipients Market Snapshot
Figure 39 Revenue Analysis of Key Players, 2020-2024 (USD Million)
Figure 40 Market Share Analysis of Key Players in Pharmaceutical Excipients Market, 2024
Figure 41 Ev/Ebitda of Key Vendors
Figure 42 Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 43 Pharmaceutical Excipients Market: Brand/Product Comparison
Figure 44 Pharmaceutical Excipients Market: Company Evaluation Matrix (Key Players), 2024
Figure 45 Pharmaceutical Excipients Market: Company Footprint
Figure 46 Pharmaceutical Excipients Market: Company Evaluation Matrix (Startups/Smes), 2024
Figure 47 International Flavors & Fragrances Inc.: Company Snapshot (2024)
Figure 48 Adm: Company Snapshot (2024)
Figure 49 Roquette Frères: Company Snapshot (2024)
Figure 50 Basf Se: Company Snapshot (2024)
Figure 51 Evonik: Company Snapshot (2024)
Figure 52 Ashland: Company Snapshot (2024)
Figure 53 Kerry Group plc: Company Snapshot (2024)
Figure 54 Merck: Company Snapshot (2024)
Figure 55 Associated British Foods plc: Company Snapshot (2024)
Figure 56 Wacker Chemie Ag: Company Snapshot (2024)
Figure 57 Air Liquide: Company Snapshot (2024)
Figure 58 Dow: Company Snapshot (2024)
Figure 59 Berkshire Hathaway: Company Snapshot (2024)
Figure 60 Croda International plc: Company Snapshot (2024)
Figure 61 Shin-Etsu Chemical Co., Ltd.: Company Snapshot (2024)

Companies Mentioned

  • International Flavors & Fragrances Inc.
  • Adm
  • Roquette Frères
  • Basf Se
  • Evonik
  • Ashland
  • Kerry Group plc
  • Merck
  • Associated British Foods plc
  • Wacker Chemie Ag
  • Air Liquide
  • Dow
  • Berkshire Hathaway (Lubrizol Corporation)
  • Colorcon, Inc.
  • Dfe Pharma
  • Actylis
  • Croda International plc
  • Chemie Trade
  • Gattefossé
  • J. Rettenmaier & Söhne GmbH + Co Kg
  • Shin-Etsu Chemical Co., Ltd.
  • Innophos
  • Meggle GmbH & Co. Kg
  • Fuji Chemical Industries Co., Ltd.
  • Corel Pharma Chem
  • Biogrund
  • Nitika Pharmaceutical Specialties Pvt. Ltd.
  • R.T. Vanderbilt Holding Company, Inc.
  • Beneo
  • Siagachi Industries
  • Jh Nanhang Life Sciences Co., Ltd.

Table Information